Savella Oral Tablet 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Savella: Oral tablet (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_11579.JPG
Savella 100mg Tab
Actavis- US Brands formerly Forest Pharmaceuticals Inc
Pill Identification: FL  |  100

What is this Medicine?

MILNACIPRAN (mil NA si pran) is used to treat the pain caused by fibromyalgia.

CVS Pharmacy Patient Statistics for Savella: Oral tablet(100mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Savella 100mg Tablet

NDC: 004561510
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Fibromyalgia

Sometimes used for but not FDA approved for the following conditions:
Depression

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Savella 100mg Tablet
Drug Image file DrugItem_11579.JPG
Actavis- US Brands formerly Forest Pharmaceuticals Inc
Pill Identification: FL  |  100
Shape: oval
Color: pink

Reported Side Effects for Savella 100mg Tablet

Decreased Urination Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Pain Of The Urethra Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Tired Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Heartburn Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Metallic Taste Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Confusion Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Chills Incidence:
1.0-2.0%*
Severity: MILD
Onset: RAPID
Painful Urination Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Hypoesthesia Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Bladder Infection Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
High Cholesterol Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Irritability Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Weight Gain Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Weight Loss Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Night Sweats Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
>2.0%*
Severity: MODERATE
Onset: DELAYED
Shortness Of Breath Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Decreased Sexual Desire Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
2.0-3.0%*
Severity: MILD
Onset: DELAYED
Flushing Incidence:
2.0-3.0%*
Severity: MILD
Onset: RAPID
Ejaculation Dysfunction Incidence:
>2.0%*
Severity: MODERATE
Onset: DELAYED
Chest Pain Incidence:
2.0-3.0%*
Severity: MODERATE
Onset: EARLY
Blurred Vision Incidence:
>2.0%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
2.0-3.0%*
Severity: MODERATE
Onset: RAPID
Testicular Pain Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Testicular Swelling Incidence:
>2.0%*
Severity: MODERATE
Onset: EARLY
Retaining Urine Incidence:
>2.0%*
Severity: MODERATE
Onset: EARLY
Shaking Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
2.0-3.0%*
Severity: MILD
Onset: RAPID
Prostate Infection Incidence:
>2.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
3.0-7.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
3.0-5.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
3.0-4.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
4.0-7.0%*
Severity: MODERATE
Onset: EARLY
Migraine Incidence:
4.0-6.0%*
Severity: MODERATE
Onset: EARLY
Dry Mouth Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
6.0-7.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
6.0-7.0%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
7.0-8.0%*
Severity: MODERATE
Onset: EARLY
Excessive Sweating Incidence:
8.0-9.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
10.0-11.0%*
Severity: MILD
Onset: EARLY
Hot Flashes Incidence:
11.0-12.0%*
Severity: MODERATE
Onset: EARLY
Inability To Sleep Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
15.0-16.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
17.0-19.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
35.0-39.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Savella 100mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Savella 100mg Tablet(Milnacipran HCl)
Alcohol and Milnacipran(Milnacipran HCl)
Alcohol use should be avoided during treatment with Milnacipran or Levomilnacipran. Use of alcohol while taking Milnacipran or Levomilncaipran can cause Milnacipran or Levomilnacipran to enter the bloodstream too quickly, which may cause serious side effects.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Savella

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.